| __timestamp | ImmunityBio, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4326000 | 72429000 |
| Thursday, January 1, 2015 | 226206000 | 78634000 |
| Friday, January 1, 2016 | 94391000 | 75374000 |
| Sunday, January 1, 2017 | 53821000 | 92157000 |
| Monday, January 1, 2018 | 35463000 | 93326000 |
| Tuesday, January 1, 2019 | 46456000 | 103132000 |
| Wednesday, January 1, 2020 | 71318000 | 110171000 |
| Friday, January 1, 2021 | 135256000 | 218817000 |
| Saturday, January 1, 2022 | 102708000 | 233827000 |
| Sunday, January 1, 2023 | 129620000 | 267194000 |
Unleashing insights
In the competitive landscape of the healthcare sector, understanding the financial strategies of companies like Lantheus Holdings, Inc. and ImmunityBio, Inc. is crucial. Over the past decade, these companies have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Lantheus Holdings, Inc. consistently increased its SG&A expenses, peaking at approximately 267 million in 2023, a 270% rise from 2014. In contrast, ImmunityBio, Inc. experienced a more volatile trajectory, with expenses fluctuating significantly, reaching a high of around 226 million in 2015 before stabilizing at 130 million in 2023. This divergence highlights differing strategic priorities, with Lantheus potentially focusing on steady growth and ImmunityBio navigating through periods of rapid expansion and consolidation. These insights offer a window into the operational priorities and market positioning of these two industry players.
Novo Nordisk A/S or Lantheus Holdings, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Genmab A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
SG&A Efficiency Analysis: Comparing Madrigal Pharmaceuticals, Inc. and ImmunityBio, Inc.
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ImmunityBio, Inc.
Breaking Down SG&A Expenses: Bausch Health Companies Inc. vs ImmunityBio, Inc.